Increased sales for its Life Sciences and Clinical Diagnostics businesses, as well as from the acquired Biotest business, pushed Bio-Rad's revenues up 13 percent for the quarter.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.